Bayesian analyses demonstrate tissue blood volume is not decreased during acute sickle cell pain episodes: A preliminary study

Abstract

BACKGROUND:

Pain is the most common complication of Sickle Cell Disease (SCD). Tissue oximetry properties in SCD during steady state and acute pain are not well described.

METHODS:

This was a cross sectional study of tissue oximetry properties in individuals with SCD during steady state, acute pain and healthy controls without SCD. A novel tissue oximetry device was used to better account for tissue pigmentation interference. We hypothesized that during acute SCD pain, blood volume to painful areas would be at least 10% less than steady state. Bayesian analyses of the data (with flat piors) were planned a priori because of the small projected sample size.

RESULTS:

The sample included 14 individuals (4 during crisis, 5 steady state, and 5 controls). In individuals with SCD, blood volume to the lower back was higher during crisis (0.18% of tissue volume vs. 0.14% ). Bayesian analyses yielded a 3% probability that our hypothesis (that blood volume would decrease by 10% ) was correct.

CONCLUSIONS:

During acute SCD pain, blood volume to painful areas is not decreased. Bayesian analyses were useful for interpretation of small sample data and may have utility in early phase trials for rare diseases.

Keywords

Sickle cell disease pain crisis tissue oximetry

Get full access to this article

View all access options for this article.

References

Akinola

N.O.

, et al., Subclinical ischaemic episodes during the steady state of sickle cell anaemia, J Clin Pathol 45(10) (1992), 902–906.

Raj

A.B.

, et al., Cerebral oximetry improves detection of sickle cell patients at risk for nocturnal cerebral hypoxia, Pediatr Pulmonol 41(11) (2006), 1088–94.

Bachir

, et al., Improvement of microcirculation abnormalities in sickle cell patients upon buflomedil treatment, Microvasc Res 46(3) (1993), 359–373.

Ballas

S.K.

, More definitions in sickle cell disease: Steady state v base line data, Am J Hematol 87(3) (2012), 338.

Ballas

S.K.

, Pain management of sickle cell disease, Hematol Oncol Clin North Am 19(5) (2005), 785–802, v.

Behpour

A.M.

, et al., Cerebral blood flow abnormalities in children with sickle cell disease: A systematic review, Pediatr Neurol 48(3) (2013), 188–199.

Benaron

D.A.

, et al., Continuous: Noninvasive, and localized microvascular tissue oximetry using visible light spectroscopy, Anesthesiology 100(6) (2004), 1469–1475.

Benz

E.J.J.

, Structurally Abnormal Hemoglobins: Sickle Cell Syndromes, in Harrison’s Principles of Internal Medicine, Longo

D.L.

, et al., Editors.:, McGraw-Hill: New York, 2012.

Chiang

E.Y.

and Frenette

P.S.

, Sickle cell vaso-occlusion, Hematol Oncol Clin North Am 19(5) (2005), 771–784, v.

10.

Frenette

P.S.

, Sickle cell vasoocclusion: Heterotypic, multicellular aggregations driven by leukocyte adhesion, Microcirculation 11(2) (2004), 167–177.

11.

Frenette

P.S.

, Sickle cell vaso-occlusion: Multistep and multicellular paradigm, Curr Opin Hematol 9(2) (2002), 101–106.

12.

Gareau

D.S.

, et al., Optical fiber probe spectroscopy for laparoscopic monitoring of tissue oxygenation during esophagectomies, J Biomed Opt 15(6) (2010), 061712.

13.

Kennedy

A.P.

, et al., Regional and temporal variation in oscillatory blood flow in sickle cell disease, Am J Hematol 28(2) (1988), 92–94.

14.

Lanzkron

, Carroll

C.P.

and Haywood

Jr. , The burden of emergency department use for sickle-cell disease: An analysis of the national emergency department sample database, Am J Hematol 85(10) (2010), 797–799.

15.

L’Esperance

V.S.

, et al., Peripheral vascular response to inspiratory breath hold in paediatric homozygous sickle cell disease, Exp Physiol 98(1) (2013), 49–56.

16.

Levenson

J.L.

, et al., Depression and anxiety in adults with sickle cell disease: The PiSCES project, Psychosom Med 70(2) (2008), 192–196.

17.

McClish

D.K.

, et al., Gender differences in pain and healthcare utilization for adult sickle cell patients: The PiSCES Project, J Womens Health (Larchmt) 15(2) (2006), 146–154.

18.

McClish

D.K.

, et al., Pain site frequency and location in sickle cell disease: The PiSCES project, Pain 145(1-2) (2009), 246–251.

19.

Quinn

C.T.

and Dowling

M.M.

, Cerebral tissue hemoglobin saturation in children with sickle cell disease, Pediatr Blood Cancer 59(5) (2012), 881–887.

20.

Raj

, et al., Assessment of cerebral tissue oxygenation in patients with sickle cell disease: Effect of transfusion therapy, Journal of Pediatric Hematology/Oncology 26(5) (2004), 279–283.

21.

Rodgers

G.P.

, et al., Periodic microcirculatory flow in patients with sickle-cell disease, N Engl J Med 311(24) (1984), 1534–1538.

22.

Rowley

C.A.

, et al., Microvascular oxygen consumption during sickle cell pain crisis, Blood 123(20) (2014), 3101–3104.

23.

Serjeant

G.R.

, et al., The painful crisis of homozygous sickle cell disease: Clinical features, British Journal of Haematology 87(3) (1994), 586–591.

24.

Shi

P.A.

, et al., Serial assessment of laser Doppler flow during acute pain crises in sickle cell disease, Blood Cells Mol Dis 53(4) (2014), 277–282.

25.

Tavakkoli

, et al., Effects of hydroxyurea treatment on cerebral oxygenation in adult patients with sickle cell disease: An open-label pilot study, Clinical Therapeutics 27(7) (2005), 1083–1088.

26.

Wagner

M.C.

, Eckman

J.R.

and Wick

T.M.

, Sickle cell adhesion depends on hemodynamics and endothelial activation,260–267; discussion, J Lab Clin Med 144(5) (2004), 227–228.

27.

Waltz

, et al., Normal muscle oxygen consumption and fatigability in sickle cell patients despite reduced microvascular oxygenation and hemorheological abnormalities, PLoS One 7(12) (2012), e52471.

28.

Zuzak

, et al., Imaging hemoglobin oxygen saturation in sickle cell disease patients using noninvasive visible reflectance hyperspectral techniques: Effects of nitric oxide, American Journal of Physiology Heart and Circulatory Physiology 285(3) (2003), 9.